Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome

Area of Science:

• Cardiovascular Health
• Metabolic Disorders
• Lifestyle Medicine

Background:

• Prehypertension (pHTN) and metabolic syndrome (MetS) are lifestyle diseases exacerbated by increased adiposity.
• Both conditions are intricately linked to body weight and share common pathophysiological pathways.

Purpose of the Study:

• To elucidate the relationship between adiposity, prehypertension, metabolic syndrome, and mortality.
• To understand the mechanisms linking excess weight to cardiovascular disease development.

Main Methods:

• Review of existing literature on adiposity, pHTN, MetS, and mortality.
• Analysis of pathophysiological pathways including RAAS dysregulation, inflammation, and insulin resistance.

Main Results:

• Increased adiposity drives pHTN via RAAS dysregulation and adrenergic tone.
• Excess weight in MetS potentiates hyperglycemia, insulin resistance, inflammation, and lipid dysregulation, contributing to cardiovascular disease (CVD).
• The link between pHTN/MetS and all-cause mortality is complex due to the obesity paradox in chronic diseases.

Conclusions:

• While the obesity paradox complicates mortality data, absence of excess weight is linked to longer lifespans.
• Managing weight is crucial for preventing pHTN and MetS, thereby reducing CVD risk.
• Understanding these links is vital for public health strategies promoting longevity and disease prevention.